Feature | April 02, 2012

Small Change Makes Big Difference in Compliance Rates for Follow-Up Stress Tests

Scheduling Appointments Before Patients Leave ER Doubles Likelihood of Returning for Stress Test

April 2, 2012 — Stress tests are an important tool to help diagnose narrowed arteries in people who come to the emergency room (ER) with chest pain but are not confirmed as having a heart attack. Scheduling a follow-up exercise stress test before patients leave the ER more than doubles their likelihood of following through with the test, according to research presented at the American College of Cardiology (ACC) 61st Annual Scientific Session in Chicago.

The study, conducted in Australia, showed that among patients who were given an appointment for an exercise stress test before they left the ER, 70 percent actually underwent the test, compared with 31 percent of patients who were instructed to make the appointment themselves. Patients who were asked to make their own appointments also waited longer to take the test than those with pre-scheduled appointments (median time of 316 vs. just 77 hours, respectively).

“When patients were given a referral but were asked to make their own appointment, they often did not return for the stress test, despite the extra information the stress test can provide,” said Kevin Chung, M.D., University of Notre Dame in Fremantle, Australia, and the study’s lead investigator. “Our recommendation is that patients be given an appointment time for their test before they leave the ER. It’s even better to have the test before they leave the hospital.”

Exercise stress tests are one of several tools used to evaluate whether a person’s arteries are constricted by fatty build-up, which can increase the risk for a heart attack and other problems. The test monitors the electrical activity of the heart during exercise. Doctors use this information to decide whether a patient should be treated to reduce their risk of heart problems; failing to take the test puts patients at a higher risk of having an undiagnosed heart problem and not getting timely, appropriate care.

“In the ideal world, every patient who comes to the ER with chest pain would undergo a definitive test that gives 100 percent certainty of whether or not their arteries are normal,” Chung said. “While stress testing is not perfect, it provides very useful information. Any protocol that increases the proportion of patients having a stress test would help in patient follow-up.”

Previous studies have shown that patients who go to the ER with chest pain but are not confirmed as having a heart attack face a 2 to 3 percent chance of having a heart attack or other complication within 30 days. Current recommendations suggest these “intermediate risk” patients should undergo a stress test within 72 hours after discharge from the hospital.

The study also showed that patients with a clear understanding of the reason they were being asked to do an exercise stress test were more likely to attend their appointment. “From this we postulate that patient education regarding the rationale for the test will further improve compliance,” said Chung.

The researchers compared follow-up rates among 96 patients who were given an appointment for an exercise stress test before leaving the hospital with 121 patients who were asked to schedule their own appointments.

This study was self-funded by the University of Notre Dame in Fremantle, Australia; control group data were from a study funded by the Health Department of Western Australia.

For more information: www.acc.org.

Related Content

News | Pharmaceuticals| September 26, 2016
Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of future heart attack...
smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons| September 22, 2016
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency...
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
Valtech Cardio, Cardioband Tricuspid, Cardioband Mitral, PCR London Valves 2016, study data
News | Heart Valve Technology| September 19, 2016
Valtech Cardio Ltd. announced that it will present the first-in-man data for its Cardioband Tricuspid (TR) system at...
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Results from a new study suggest that small molecules known as microRNAs may be part of the path
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Findings from a small...
News | Cardiac Diagnostics| September 12, 2016
A Saint Louis University researcher has received a grant to study the effects of treating post-traumatic stress...
congenital heart defects, CHD, risk factors, genes, University of California Irvine research
News | Congenital Heart| September 09, 2016
September 9, 2016 — New research published Sept.
Overlay Init